Feasibility of melatonin for prevention of delirium in critically ill patients: a protocol for a multicentre, randomised, placebo-controlled study

INTRODUCTION: Delirium is highly prevalent in the intensive care unit (ICU) and is associated with adverse clinical outcomes. At this time, there is no drug that effectively prevents delirium in critically ill patients. Alterations in melatonin secretion and metabolism may contribute to the developm...

Descripción completa

Detalles Bibliográficos
Autores principales: Burry, Lisa, Scales, Damon, Williamson, David, Foster, Jennifer, Mehta, Sangeeta, Guenette, Melanie, Fan, Eddy, Detsky, Michael, Azad, Azar, Bernard, Francis, Rose, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387939/
https://www.ncbi.nlm.nih.gov/pubmed/28363933
http://dx.doi.org/10.1136/bmjopen-2016-015420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387939/
https://www.ncbi.nlm.nih.gov/pubmed/28363933
http://dx.doi.org/10.1136/bmjopen-2016-015420

Ejemplares similares